The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown almost 50 years and now employs in excess of 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).
Through our continual investment in the development of our state of the art services; from cutting edge biomarker and companion diagnostics through to step changes in the management of the clinical trial data and the clinical supply chain to biocatalytic manufacture of API, Almac ensures we are always there to support you across the product development lifecycle.
More about us
Almac History, Culture and Values Video
Watch our History, Culture and Values Video to learn more about our background and vision for a successful future.Read more...
Company Overview Video
Learn more about our extensive pharmaceutical development and manufacturing services and global capabilities.Read more...
Almac is a global provider of pharmaceutical support services with thousands of employees situated throughout its global facilities. It is Almac’s policy to conduct all business in an honest and ethical manner.Read more...
Core Values & Vision
Our ultimate goal is to help advance human health globally. We are at the forefront of improving efficiency in the development of new medicines.Read more...
For more than 40 years, Almac has supported the global Biopharmaceutical industry with their drug development activities and bringing new drugs to market to advance human health.Read more...
As testament to our expertise and strong global performance, Almac is proud to have been recognised by various bodies and received an array of awards.Read more...
Sir Allen McClay
Northern Ireland lost its most passionate, visionary and generous man. Sir Allen McClay (Allen, as he preferred to be called) passed away on Tuesday 12th January, 2010.Read more...
Tax Strategy: Almac Approach
The Almac Group is a group of companies operating in the highly regulated and risk-averse pharmaceutical and biotech sectors. We adopt this same low risk strategy in our approach to our tax affairs and tax strategy.Read more...